Goldline Pharmaceutical IPO Live GMP Today
As of 18 May 2026, 02:48 pm IST, Goldline Pharmaceutical SME IPO is quoting a grey market premium of +₹15 (+34.9% over the issue price), implying a listing around ₹58 per share.
| Status | Listed |
| Type | SME |
| Open Date | May 12, 2026 |
| Close Date | May 14, 2026 |
| Listing Date | May 19, 2026 |
| Issue Size | ₹12.00 Cr |
| Date | GMP (Rs) | Change | GMP % | Est. Listing |
|---|---|---|---|---|
| May 18, 2026 02:48 pm | +15 | ▼ 2 | +34.9% | ₹58 |
| May 16, 2026 06:41 am | +17 | ▲ 2 | +39.5% | ₹60 |
| May 14, 2026 05:20 pm | +15 | ▼ 10 | +34.9% | ₹58 |
| May 13, 2026 05:07 pm | +25 | ▲ 11 | +58.1% | ₹68 |
| May 13, 2026 04:39 pm | +14 | ▼ 4 | +32.6% | ₹57 |
| May 12, 2026 08:03 pm | +18 | ▲ 1 | +41.9% | ₹61 |
| May 11, 2026 07:28 pm | +17 | ▲ 1 | +39.5% | ₹60 |
| May 11, 2026 02:02 pm | +16 | ▲ 1 | +37.2% | ₹59 |
| May 10, 2026 08:49 am | +15 | ▲ 7 | +34.9% | ₹58 |
| May 09, 2026 10:23 am | +8 | ▲ 2 | +18.6% | ₹51 |
| May 08, 2026 04:30 pm | +6 | ▲ 6 | +14.0% | ₹49 |
| May 08, 2026 12:30 pm | +0 | — | +0.0% | ₹43 |
Goldline Pharmaceutical IPO GMP — Detailed Analysis
What Goldline Pharmaceutical GMP Tells Us Today
The current Grey Market Premium for Goldline Pharmaceutical IPO is Rs 15 (34.9% over the issue price). Based on this GMP, the implied listing price hovers around Rs 58 per share. Across the 12 GMP records captured for this issue, the trend has been rising by Rs 15 — a useful directional signal for gauging investor sentiment as the listing date approaches.
Goldline Pharmaceutical IPO is expected to list on May 19, 2026.
Goldline Pharmaceutical IPO GMP — FAQs
New to grey market data? The hub covers how to read a GMP trend and how SME GMP compares with actual listing performance, and our explainer goes deeper: What is IPO GMP?